Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: Chiesi Hellas A.E.B.E., Geroulanou sq & 1, Renou Poggi str., 17455 Alimos, Greece
Clenil forte SPRAY 250mcg pressurised inhalation solution.
| Pharmaceutical Form |
|---|
|
Pressurised inhalation solution (containing HFA 134a – norflurane as propellant). It does not contain any substance damaging to the ozonosphere. |
Each canister contains:
Active ingredient: Beclometasone-17,21-dipropionate 50mg (each actuation delivers 250 micrograms).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Beclometasone |
Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. |
| List of Excipients |
|---|
|
HFA 134a (norflurane, ethanol, glycerol) |
Primary package: pressurised aluminium canister fitted with metering valve, actuator and protecting cap.
Outer package: printed thin cardboard box.
Pressurised canister providing 200 inhalations.
Chiesi Hellas A.E.B.E., Geroulanou sq & 1, Renou Poggi str., 17455 Alimos, Greece
12678
5th August 1989 / 22nd February 2000
| Drug | Countries | |
|---|---|---|
| CLENIL | Albania, Brazil, Cyprus, Hong Kong, Ireland, Italy, Romania, Singapore, Tunisia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
